TriangleNCT00354172 · OUTCOME
Number of Participants (Patients) Who Attained Platelet Engraftment
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 1 Year Post Transplant
What was measured
Platelet engraftment is defined as platelet counts \> 50 x 10\^9/Liter for 3 consecutive days.
Groups in this outcome
Evaluable Patients
All patients receiving full study treatment with chemotherapy and radiation, along with natural killer cells, aldesleukin and umbilical cord blood transplant.
| Group | Source count |
|---|---|
| Evaluable Patients | 15 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Evaluable Patients | 5 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- anticipated Posting Date
- 2009-11
- classes
- categories
- measurements
- group Id
- OG000
- value
- 5
- denoms
- counts
- group Id
- OG000
- value
- 15
- units
- Participants
- description
- Platelet engraftment is defined as platelet counts \> 50 x 10\^9/Liter for 3 consecutive days.
- groups
- description
- All patients receiving full study treatment with chemotherapy and radiation, along with natural killer cells, aldesleukin and umbilical cord blood transplant.
- id
- OG000
- title
- Evaluable Patients
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- 1 Year Post Transplant
- title
- Number of Participants (Patients) Who Attained Platelet Engraftment
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice